Marco Panella

No ORCID on file · 1 paper in corpus
rct 2022
BMC women's health ·doi:10.1186/s12905-022-01737-7

BACKGROUND: To evaluate the effects of a combined oral contraceptive containing 1.5 mg 17b-estradiol (E2) and 2.5 mg nomegestrol acetate (NOMAC) or 2 mg/daily dienogest (DNG) oral progestin on endometriosis-associated chronic pelvic pain (C…